Doximity, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Doximity, Inc. on August 4, 2022. The filing primarily serves to announce the company's financial results for the fiscal quarter ended June 30, 2022, and to disclose changes to the Board of Directors.
Financial Metrics
The filing references a press release (Exhibit 99.1) containing the detailed financial results for the quarter ended June 30, 2022. However, the text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes and Corporate Governance
Significant changes to the Board of Directors were announced effective August 2, 2022:
- Director Resignation: Gilbert Kliman, M.D., resigned from the Board and its nominating/governance and compensation committees. The departure was not due to any disagreement with the company.
- Director Appointment: Phoebe L. Yang Watkin was appointed as a Class III director to fill the vacancy. She will serve on the nominating and governance committee and the compensation committee until the 2024 Annual Meeting.
Compensation and Outlook
Ms. Yang's compensation package includes:
- Annual Board compensation: $30,000
- Annual Compensation Committee compensation: $6,000
- Annual Nominating and Governance Committee compensation: $4,000
- Initial grant of restricted stock units (RSUs) valued at $350,000, vesting in equal annual installments over three years.
The filing does not contain specific management commentary on future guidance, risks, or contingencies beyond the standard incorporation of the press release.
Key Facts for Investor Verification
- Verify the specific Q1 2023 financial metrics (revenue, net income, cash flow) in the attached press release (Exhibit 99.1), as they are not listed in this summary text.
- Confirm the effective date of the Board changes (August 2, 2022) and the tenure of the new director (until the 2024 Annual Meeting).
- Note that the financial information in this filing is not deemed "filed" under Section 18 of the Exchange Act.